NP Thyroid false ad $41.4M class action settlement

Acella agreed to a $41.4 million NP Thyroid settlement to resolve claims it falsely advertised the thyroid medication as containing a specified amount of the active ingredient.

The settlement benefits individuals who received a dispensed prescription for NP Thyroid between May 12, 2018, and April 30, 2021, whether Acella recalled the NP Thyroid lots or not.

According to the false advertising class action lawsuit, Acella’s NP Thyroid had an inconsistent amount of the active ingredient. Some batches of the medication allegedly contained too much of the active ingredient while other batches contained too little, making the medication ineffective or unsafe.

Acella manufactures NP Thyroid, a thyroid medication that treats hypothyroidism.

Acella hasn’t admitted any wrongdoing but agreed to pay more than $41.4 million to resolve the class action lawsuit.

Under the terms of the NP Thyroid settlement, class members can receive up to $10 without any documentation of the prescriptions they received. With additional documentation, class members can collect up to $50 for the prescriptions they received.

The deadline for exclusion and objection is April 22, 2024.

The final approval hearing for the settlement was scheduled for May 14, 2024.

To receive NP Thyroid settlement benefits, class members must submit a valid claim form by Nov. 30, 2024.

Who’s Eligible

Individuals who received a dispensed prescription for NP Thyroid between May 12, 2018, and April 30, 2021, whether Acella recalled the NP Thyroid lots or not

Potential Award

$50

Proof of Purchase

Documentation of filled prescriptions (pharmacy receipt, pharmacy records and records from insurance providers)

Claim Form

NOTE: If you do not qualify for this settlement do NOT file a claim.

Remember: you are submitting your claim under penalty of perjury. You are also harming other eligible Class Members by submitting a fraudulent claim. If you’re unsure if you qualify, please read the FAQ section of the Settlement Administrator’s website to ensure you meet all standards (Top Class Actions is not a Settlement Administrator). If you don’t qualify for this settlement, check out our database of other open class action settlements you may be eligible for.

Claim Form Deadline

11/30/2024

Case Name

Faulkner, et al. v. Acella Pharmaceuticals LLC, Case No. 2:22-cv-00092-RWS, in the U.S. District Court for the Northern District of Georgia

Final Hearing

05/14/2024

Claims Administrator

AF9 Claims Administrator
P.O. Box 301172
Los Angeles, CA 90030-1172
[email protected]
877-519-1122

Class Counsel

Aaron Block
Max Marks
THE BLOCK LAW FIRM LLC

Defense Counsel

David F Norden
TROUTMAN PEPPER HAMILTON SANDERS LLP